Fixing the root cause of diabetes

Hebrew University of Jerusalem Professor Motti Chevion has developed Zygosid-50, the first treatment to restore near-normal cellular sensitivity to insulin, without side effects. Israel’s Concenter BioPharma is preparing to trial Zygosid-50 and give new hope to Type 2 diabetics.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *